NEWS
Paul Hastings Advised TD Securities in Forte Biosciences’ Oversubscribed Private Placement
November 20, 2024
Paul Hastings LLP advised TD Securities (USA) LLC as lead placement agent in connection with Forte Biosciences, Inc.’s (NASDAQ: FBRX) oversubscribed $53 million PIPE financing.
The Paul Hastings team included Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and partner Will Magioncalda.
More details can be found here.
About Paul Hastings
With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.
Practice Areas
Securities and Capital Markets
SIGN UP FOR NEWS INSIGHTS
MEDIA CONTACTS
Corporate, Litigation, Real Estate, Intellectual Property, Life Sciences, and Employment
Becca Hatton